HMGB1 and neoplasm: For instance, kinase inhibitors or tumor-directed cytotoxic agents induce immunogenic cell death, leading to the release of damage-associated molecular patterns (DAMPs), such as HMGB1 and ATP, which APCs including dendritic cells and Langerhans cells (111).